Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


​The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 

 

The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor
AmnioChor Inc. announced that the Musculoskeletal Transplant Foundation of Edison NJ has agreed to invest in their seed round of development of the proprietary AmnioCept™ product line and OmniBank placental tissue storage capabilities. AmnioChor's products are intended to augment umbilical cord blood, and will additionally contain epithelial and mesenchymal stem cells that may be used in technologies including 3-D printing of human organs. [AmnioChor Inc. (PR Newswire Association LLC)] Press Release

 

Posted on 18-Aug-15 by Berry, Cassie
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: